Sumitomo Mitsui Trust Group, Inc.

Position in ALKS — Alkermes plc.

CIK 1475365 CHIYODA-KU, TOKYO, M0

Back to ALKS Full portfolio

Position in ALKS

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$491,504

+$117,412 QoQ

Shares Held

13,900

+4.0% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ALKS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Sumitomo Mitsui Trust Group, Inc. holds $263,345,665 across 8 Drug Manufacturers - Specialty & Generic names. ALKS ranks #6 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	963,773	$113,927,606
2	TEVA	Teva Pharmaceutical Industries Ltd	2,173,839	$65,476,030
3	UTHR	UNITED THERAPEUTICS Corp	88,637	$52,559,968
4	NBIX	Neurocrine Biosciences Inc	220,449	$29,041,951
5	VTRS	Viatris Inc	85,015	$1,148,552
6	ALKS	Alkermes plc. This page	13,900	$491,504
7	INDV	Indivior Pharmaceuticals, Inc.	15,420	$470,001
8	LNTH	Lantheus Holdings, Inc.	3,033	$230,053

All Filings in ALKS

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$491,504	13,900	+4.0%	Shares	Defined	2026-04-30
2025-12-31	$374,092	13,370	+17.3%	Shares	Defined	2026-01-23
2024-09-30	$319,086	11,400	-12.3%	Shares	Defined	2024-11-05
2024-06-30	$313,300	13,000	+52.9%	Shares	Defined	2024-07-19
2024-03-31	$230,095	8,500	-15.0%	Shares	Defined	2024-04-19
2023-12-31	$277,400	10,000	0.0%	Shares	Defined	2024-01-30
2023-09-30	$280,100	10,000	-37.8%	Shares	Defined	2023-10-30
2022-12-31	$420,039	16,075	—	Shares	Defined	2023-01-30
No filing history on record for this holder in this stock.